Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alberto Papi (Ferrarra, Italy). Diagnostic, aetiology and assessment of exacerbations. International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic contribution of PICADAR score in etiological evaluation of patients with bronchiectasis of unknown etiology Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 COPD exacerbation definitions, assessment and diagnosis Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Diagnostic approach to and phenotyping of severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Diagnosis and assessment of asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=180 Year: 2003 Clinical assessment and staging of COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Diagnostic characteristics of questionnaires for identification of obstructive lung disease Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Diagnostic work-up and treatment of patients with acute ILDs Source: International Congress 2018 – PG15 Challenging issues in acute interstitial lung diseases Year: 2018 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Diagnostic work-up in patients with acute ILDs Source: International Congress 2017 – PG11 Acute interstitial lung diseases (ILD) Year: 2017 Systematic assessment of difficult-to-treat asthma Source: Eur Respir J 2003; 22: 478-483 Year: 2003 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Validity of general practitioner-made diagnosis of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 688s Year: 2004 Usefulness of the forced oscillation technique in diagnosing asthma-COPD overlap syndrome Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease Year: 2016 Clinical diagnosis of COPD Source: Virtual Congress 2020 – Russian speaking programme 2020: Part II Year: 2020 Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease Source: International Congress 2014 – COPD markers Year: 2014 Clinical significance of aspergillus isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015